Cellular Goods PLC Director's Dealings (1385Z)

TIDMCBX

RNS Number : 1385Z

Cellular Goods PLC

10 January 2024

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

10 January 2024

Cellular Goods PLC

("Cellular Goods" or "The Company")

Director's Dealings

Cellular Goods (LSE: CBX), a UK-based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, announces that Michael Edwards (Executive Director of Cellular Goods) has purchased a total of 2,500,000 ordinary shares in the Company ("Ordinary Shares"), the details of which are set out in the notification below. F ollowing this purchase, Michael Edwards holds a total of 8,000,000 Ordinary Shares, representing 1.33 per cent of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
       Details of the person discharging managerial responsibilities 
  1.    / person closely associated 
 a)    Name                            Michael Edwards 
      ------------------------------  ------------------------------------- 
       Reason for the Notification 
  2. 
      --------------------------------------------------------------------- 
 a)    Position/status                 Executive Director 
      ------------------------------  ------------------------------------- 
 b)    Initial notification            Initial notification 
        / Amendment 
      ------------------------------  ------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3.    auction platform, auctioneer or auction monitor 
      --------------------------------------------------------------------- 
 a)    Name                            Cellular Goods PLC 
      ------------------------------  ------------------------------------- 
 b)    LEI                             213800IXPX4Z2MKX2U28 
      ------------------------------  ------------------------------------- 
 4.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of 
        transaction; (iii) each date; and (iv) each place where 
        transactions have been conducted 
      --------------------------------------------------------------------- 
 a)    Description of the              Ordinary shares 
        Financial instrument, 
        type of instrument 
       Identification Code             GB00BK964W87 
      ------------------------------  ------------------------------------- 
 b)    Nature of the transaction       Purchase of shares 
      ------------------------------  ------------------------------------- 
 c)    Price(s) and volume(s)           Price(s)        Volume(s) 
                                         0.417 pence     2,500,000 Ordinary 
                                          per Ordinary    Shares 
                                          Share 
                                                        ------------------- 
      ------------------------------  ------------------------------------- 
 d)         Aggregated information: 
              *    Aggregated volume     2,500,000 Ordinary Shares 
                                         0.417 pence per Ordinary Share 
 
              *    Price 
      ------------------------------  ------------------------------------- 
 e)    Date of the transaction         09 January 2024 
      ------------------------------  ------------------------------------- 
 f)    Place of the Transaction        London Stock Exchange 
      ------------------------------  ------------------------------------- 
 

For further information please contact:

 
 Cellular Goods 
 Michael Edwards                     via FSCF [phone] 
  Director 
                                    -------------------------- 
 First Sentinel Corporate Finance 
  (FSCF) 
                                    -------------------------- 
 Investor Relations 
  Rebecca Noonan                       [phone] 
  [e-mail] 
  Media Relations 
  Rebecca Noonan                       [phone] 
  [e-mail] 
  Corporate Broker & Advisor 
  Brian Stockbridge                    [phone] 
                                    -------------------------- 
 Novum Securities 
                                    -------------------------- 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                          [phone] 
                                    -------------------------- 
 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDZGGMKLGGDZM

(END) Dow Jones Newswires

January 10, 2024 02:00 ET (07:00 GMT)